![researcher studying diseases in a lab](/sites/default/files/styles/split_page_header/public/2024-05/Screenshot%202024-05-07%20at%2012.36.38%E2%80%AFPM.png?h=649b49ca&itok=64_0qZva)
Funding Opportunities
Maternal and Pediatric HIV/AIDS Research
Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 - Clinical Trial Not Allowed)
of HIV on the Health Across the Lifespan of Women
Notice of Special Interest (NOSI) on Catalyzing Research and Training on the Impact of HIV on the Health Across the Lifespan of Women Living with HIV Through Administrative Supplements to Existing Fogarty International Center’s HIV Programs
Infectious Diseases Network
Explore opportunities to join an emerging infectious diseases network with the NIH
DP1 Clinical Trial Optional
NIH Director’s Pioneer Award Program (DP1 Clinical Trial Optional)
NIH - Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional)
Intramural Clinical Research Scholar Transition Award
NIH Director’s Transformative Research Awards
Several key features of this NOFO are designed to emphasize to applicants and peer reviewers that Transformative Research applications are very different from conventional, investigator-initiated research applications.
Advancing HIV service delivery through pharmacies and pharmacists
The purpose of this Notice of Funding Opportunity (NOFO) is to solicit research designed to capacitate, transform, and scale the delivery of HIV testing, prevention, and care services through pharmacists and pharmacies in US and/or global settings.
Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Coordinating Center Infrastructure to Support Research on Opioid Overdose and HIV Risk in the Context of Justice Systems
The National Institute on Drug Abuse (NIDA) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for coordinating center infrastructure to support research on opioid overdose —a national public health emergency declared by the Department of Health and Human Services since October 26, 2017— and HIV risk in the context of justice system.
BJA FY24 Comprehensive Opioid, Stimulant and Substance Use Program (COSSUP) Overdose Fatality Review (OFR) Training and Technical Assistance (TTA)
With this solicitation, BJA seeks a training and technical assistance (TTA) provider to help jurisdictions prevent and reduce overdose deaths as part of the Comprehensive Opioid, Stimulant, and Substance Use Program (COSSUP).
Minority AIDS Initiative: A Pilot Program to Strengthen Prevention and Treatment Services for Substance Use Disorders, HIV/AIDS, and Other Infectious Diseases
The purpose of this program is to provide substance use prevention, substance use disorder (SUD) treatment, HIV, and viral hepatitis prevention and treatment services for racial and ethnic individuals vulnerable to a SUD and/or mental health condition, HIV, viral hepatitis, and other infectious disease (e.g., sexually transmitted infections). Recipients